United Therapeutics CEO Chairperson Martine Rothblatt disposes of 9,500 shares worth $5.03 million - UTHR News | RalliesUnited Therapeutics CEO Chairperson Martine Rothblatt disposes of 9,500 shares worth $5.03 million
U
UTHR• Insider share transactions
- United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at $135.42.
- A family trust sold 9,500 shares at weighted average prices of about $525.29 to $540.32 on Aug. 7, 2026.
- The trust ended with 324,443 shares of common stock, down from 333,943 shares before the transactions.
FSUN
•
